Brett Fishman
Analyst, KeyBank Capital Markets
Replay available
LeMaitre Vascular, Inc. (NASDAQ: LMAT) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.

Analyst, KeyBank Capital Markets
Analyst, Citizens JMP
Analyst, Barrington Research
Analyst, Roth Capital Partners
Chief Executive Officer
Analyst, Stifel
Analyst, Sidoti & Co
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Lemaitre Vascular, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.137 Welcome to the LeMaitre Vascular Q4 2025 Financial Results 00:00:05.137 -- 00:00:10.403 Conference Call. As a reminder, today's call is being recorded. 00:00:10.403 -- 00:00:13.887 At this time, I would like to turn the call over to Mr. 00:00:13.887 -- 00:00:18.573 Dorian LeBlanc, Chief Financial Officer of LeMaitre Vascular. 00:00:18.573 -- 00:00:21.214 Please go ahead, sir. 00:00:23.118 -- 00:00:28.505 Thank you. Good afternoon, and thank you for joining us on our Q4 2025 Conference 00:00:28.505 -- 00:00:33.627 Call. With me on today's call is our CEO, George LeMaitre, and our president, Dave 00:00:33.627 -- 00:00:38.213 Roberts. Before we begin, I'll read our safe harbor statement. 00:00:38.213 -- 00:00:41.738 Today, we'll be making some forward-looking statements within the meaning of the U.S. 00:00:41.738 -- 00:00:45.263 Private Securities Litigation Reform Act of 1995, 00:00:45.263 -- 00:00:48.568 the accuracy of which is subject to risks and uncertainties. 00:00:48.568 -- 00:00:52.514 Wherever possible, we will try to identify those forward-looking statements by using 00:00:52.514 -- 00:00:55.178 words such as believe, expect, 00:00:55.178 -- 00:00:58.102 anticipate, pursue, forecast, 00:00:58.102 -- 00:01:02.065 and similar expressions. Our forward-looking statements are based on our estimates and 00:01:02.065 -- 00:01:07.153 assumptions as of today, February 25, 2026, and should not be relied upon as representing 00:01:07.153 -- 00:01:10.178 our estimates or views on any subsequent date. 00:01:10.178 -- 00:01:13.262 Please refer to the cautionary statement regarding forward-looking information and the 00:01:13.262 -- 00:01:18.691 risk factors in our most recent 10-K and subsequent SEC filings, including disclosure 00:01:18...